Dow Acquires Wolff Walsrode Business from Bayer

Dow Chemical’s recent acquisition of Bayer’s Wolff Walsrode (Walsrode, Germany) cellulosics subsidiary, strengthens Dow’s differentiated portfolio and reduces its earnings cyclicality, says David Begleiter, analyst at Deutsche Bank (New York). Deutsche Bank estimates that Dow paid about $585 million for the business. The deal is expected to close in the first half, and is subject to regulatory approval. Kreinberg: Creating a $1-billion business. Wolff Walsrode had 2005 revenues of more than $400 million, and will be integrated into Dow’s...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers